Direct Meds
- Limited-time offer: plans starting from $199/mo
- Licensed clinicians and unlimited messaging support
- Quick online intake. Fast free shipping. Cancel anytime.

Compare leading online programs for GLP-1 treatments like semaglutide and tirzepatide, and learn how they work, what to expect and who may be eligible.
We may earn a commission from offers on this page, which can affect how they appear. Advertiser Disclosure.
CompareTreatments Rx Editorial Team
Updated October 2026
| Provider | Our Score | Best For | |
|---|---|---|---|
| Direct Meds | 9.2/10 | Best Pricing | Visit Site |
| Henry Meds | 8.8/10 | Most Popular | Visit Site |
In just a few years, weekly GLP-1 injections have gone from niche diabetes drugs to one of the most talked-about tools in weight care. Telehealth programs make it easier to get evaluated and prescribed without repeated in-person visits, which helps explain why so many people are exploring them.
GLP-1 stands for glucagon-like peptide-1, a hormone your gut releases after eating. GLP-1 medications are lab-made versions that last much longer in the body than the natural hormone. They're prescribed alongside healthier eating and more physical activity to help people with obesity or weight-related health conditions lose weight.
These medications act on several systems at once:
A once-weekly injection approved for chronic weight management in adults and some teens. Semaglutide is also the active ingredient in Ozempic, which is approved for type 2 diabetes.
A once-weekly injection that acts on two hormone pathways, GLP-1 and GIP. The same ingredient is sold as Mounjaro for type 2 diabetes.
An older, once-daily GLP-1 injection for weight management. It's generally less effective than the weekly options, but it has a longer track record.
Some clinicians prescribe the diabetes versions (Ozempic, Mounjaro) off-label for weight loss. Insurance coverage for this use is often limited.
Some online programs offer compounded versions, which are not FDA-approved. Ask your provider what you're being prescribed.
Prescribing guidelines usually cover adults who have:
These drugs generally aren't recommended if you're pregnant, or if you have a personal or family history of medullary thyroid cancer or MEN 2 syndrome. A clinician will review your full history first.
Results depend on the medication, the dose and how long you take it. In large clinical trials, people on weekly semaglutide lost an average of roughly 15% of their body weight over about 16 months. People on the highest doses of tirzepatide averaged around 20% over about 17 months. Individual results vary widely.
~15%
Average trial weight loss, semaglutide
~20%
Average trial weight loss, tirzepatide (top dose)
Most weekly options come in pre-filled pens or vials with a very fine needle. You inject just under the skin of your stomach, thigh or upper arm, and it takes a few seconds. Many people say it's far easier than they expected. Your provider will usually start you on a low dose and raise it gradually every few weeks.
Stomach-related side effects are the most common, especially when you start or increase your dose:
Rarer but serious risks include pancreatitis, gallbladder problems and kidney issues. Contact a doctor right away if you have severe stomach pain or other worrying symptoms.
These medications often produce more weight loss than earlier drugs. Once-weekly dosing is convenient, and some people see added benefits like better blood sugar and blood pressure. Online programs remove many of the usual hurdles: there's no waiting room, pricing is upfront and medication is delivered to your home.
GLP-1 injections can be an effective part of a long-term weight plan when they're prescribed and monitored by a licensed clinician. If you're comparing online options, look at total monthly cost, how much support you get and how the medication is sourced. Direct Meds and Henry Meds are our top picks to start with.
It depends on your health, budget and goals. Tirzepatide tends to show the greatest average weight loss in studies, while semaglutide has a longer track record. A clinician can help you choose.
Trial averages range from about 15% to 20% of body weight over a year or more, but individual results vary.
Wegovy, Zepbound and Saxenda are FDA-approved for weight management. Compounded versions are not FDA-approved.
Semaglutide and tirzepatide are taken once a week. Liraglutide is taken daily.
They're designed to be used alongside healthier eating and activity, which usually leads to better, longer-lasting results.
For most eligible adults, they're considered safe when prescribed and monitored by a clinician. They do carry side effects and aren't right for everyone.
Many people notice less appetite within the first few weeks. Steady weight loss usually builds over several months as the dose increases.
Many people regain some weight after stopping, so talk with your provider about a long-term plan.
Direct Meds
Score 9.2 · Best Pricing